albuterol has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Almeida, GM | 1 |
| Scola, RH | 1 |
| Ducci, RDP | 1 |
| Cirino, RHD | 1 |
| Cláudia, SKK | 1 |
| Lorenzoni, PJ | 1 |
| Lima, PHS | 1 |
| de Oliveira, LP | 1 |
| Werneck, LC | 1 |
| Khoury, SJ | 1 |
| Healy, BC | 1 |
| Kivisäkk, P | 1 |
| Viglietta, V | 1 |
| Egorova, S | 1 |
| Guttmann, CR | 1 |
| Wedgwood, JF | 1 |
| Hafler, DA | 1 |
| Weiner, HL | 1 |
| Buckle, G | 1 |
| Cook, S | 1 |
| Reddy, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Multiple Sclerosis With Copaxone (Glatiramer Acetate) and Albuterol[NCT00039988] | 40 participants (Actual) | Interventional | 2001-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for albuterol and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study.
Topics: Adolescent; Adult; Aged; Albuterol; Brazil; Double-Blind Method; Fatigue; Humans; Middle Aged; Multi | 2020 |
A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.
Topics: Adjuvants, Immunologic; Adrenergic beta-Agonists; Adult; Albuterol; Double-Blind Method; Drug Admini | 2010 |